Review



pld2 inhibitor cay10594  (Cayman Chemical)


Bioz Verified Symbol Cayman Chemical is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Cayman Chemical pld2 inhibitor cay10594
    Pld2 Inhibitor Cay10594, supplied by Cayman Chemical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cay10594/pld1+inhibitor+vu0155069/pm37691020-68-24-28
    Average 90 stars, based on 1 article reviews
    pld2 inhibitor cay10594 - by Bioz Stars, 2026-08
    90/100 stars

    Images



    Similar Products

    93
    MedChemExpress cay10594 powder
    Cay10594 Powder, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cay10594/CAY10594/pm41110487-32-7-13
    Average 93 stars, based on 1 article reviews
    cay10594 powder - by Bioz Stars, 2026-08
    93/100 stars
      Buy from Supplier

    90
    TargetMol cay10594
    Figure 6. D-AS2 promotes PLD/PA-mediated YAP activation. A, Western blot analyses of YAP and LATS1 phosphorylation. KYSE450 cells expressing EV or D-AS2 were pretreated with FIPI (30 mmol/L) or <t>CAY10594</t> (20 mmol/L) for 1 hour. Representative results of at least three biological replicates are shown. B, qRT-PCR detection of the YAP target genes CTGF and CYR61. KYSE450 cells expressing EV or D-AS2 were pretreated with FIPI (30 mmol/L) or CAY10594 (20 mmol/L) for 1 hour. The data are presented as the mean SD values; two-tailed t test; , P < 0.001; n ¼ 3 technical replicates. C and D, IF detection of YAP localization in KYSE450 cells expressing EV or D-AS2. Cells were pre- treated with FIPI (30 mmol/L) or CAY10594 (20 mmol/L). YAP localization is shown in C. Scale bar, 30 mm. Cells from three different fields in three independent experiments were randomly selected for quantification of YAP localization (D). The data are expressed as the mean SEM values. E, Western blot analyses of YAP and LATS1 phosphorylation. Serum-starved KYSE30 cells expressing control or D-AS2–target- ing sgRNAs were pretreated with PA (100 mmol/L) for 1 hour. Representative results of at least three biological replicates are shown. F, qRT-PCR detection of the YAP target genes CTGF and CYR61. Serum- starved KYSE30 cells expressing control or D-AS2–targeting sgRNAs were pretreated with PA (100 mmol/L) for 1 hour. The data are presented as the mean SD values; two-tailed t test; , P < 0.001; ns, not significant; n ¼ 3 technical replicates. G and H, IF detection of YAP localization in KYSE30 cells expressing control and D-AS2–targeting sgRNAs and pretreated with PA (100 mmol/L) for 1 hour. YAP local- ization is shown in G. Scale bar, 30 mm. Cells from three different fields in three independent experiments were randomly selected for quantification of YAP localiza- tion (H). The data are expressed as the mean SEM values. I, qRT-PCR detection of the expression of the indicated genes in the samples with chemoresistance or chemosensitivity of patients with esoph- ageal SCC. The data are presented as the mean SEM values; two-tailed t test; n ¼ 17 for chemoresistant patients; n ¼ 17 for chemosensitive patients.
    Cay10594, supplied by TargetMol, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cay10594/CAY10594/10__1158_slash_0008___5472__can___22___0717-94-3-8
    Average 90 stars, based on 1 article reviews
    cay10594 - by Bioz Stars, 2026-08
    90/100 stars
      Buy from Supplier

    92
    Santa Cruz Biotechnology cay10594
    Figure 6. D-AS2 promotes PLD/PA-mediated YAP activation. A, Western blot analyses of YAP and LATS1 phosphorylation. KYSE450 cells expressing EV or D-AS2 were pretreated with FIPI (30 mmol/L) or <t>CAY10594</t> (20 mmol/L) for 1 hour. Representative results of at least three biological replicates are shown. B, qRT-PCR detection of the YAP target genes CTGF and CYR61. KYSE450 cells expressing EV or D-AS2 were pretreated with FIPI (30 mmol/L) or CAY10594 (20 mmol/L) for 1 hour. The data are presented as the mean SD values; two-tailed t test; , P < 0.001; n ¼ 3 technical replicates. C and D, IF detection of YAP localization in KYSE450 cells expressing EV or D-AS2. Cells were pre- treated with FIPI (30 mmol/L) or CAY10594 (20 mmol/L). YAP localization is shown in C. Scale bar, 30 mm. Cells from three different fields in three independent experiments were randomly selected for quantification of YAP localization (D). The data are expressed as the mean SEM values. E, Western blot analyses of YAP and LATS1 phosphorylation. Serum-starved KYSE30 cells expressing control or D-AS2–target- ing sgRNAs were pretreated with PA (100 mmol/L) for 1 hour. Representative results of at least three biological replicates are shown. F, qRT-PCR detection of the YAP target genes CTGF and CYR61. Serum- starved KYSE30 cells expressing control or D-AS2–targeting sgRNAs were pretreated with PA (100 mmol/L) for 1 hour. The data are presented as the mean SD values; two-tailed t test; , P < 0.001; ns, not significant; n ¼ 3 technical replicates. G and H, IF detection of YAP localization in KYSE30 cells expressing control and D-AS2–targeting sgRNAs and pretreated with PA (100 mmol/L) for 1 hour. YAP local- ization is shown in G. Scale bar, 30 mm. Cells from three different fields in three independent experiments were randomly selected for quantification of YAP localiza- tion (H). The data are expressed as the mean SEM values. I, qRT-PCR detection of the expression of the indicated genes in the samples with chemoresistance or chemosensitivity of patients with esoph- ageal SCC. The data are presented as the mean SEM values; two-tailed t test; n ¼ 17 for chemoresistant patients; n ¼ 17 for chemosensitive patients.
    Cay10594, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cay10594/CAY10594/pm40499840-122-175-176
    Average 92 stars, based on 1 article reviews
    cay10594 - by Bioz Stars, 2026-08
    92/100 stars
      Buy from Supplier

    90
    Millipore cay10594
    Figure 6. D-AS2 promotes PLD/PA-mediated YAP activation. A, Western blot analyses of YAP and LATS1 phosphorylation. KYSE450 cells expressing EV or D-AS2 were pretreated with FIPI (30 mmol/L) or <t>CAY10594</t> (20 mmol/L) for 1 hour. Representative results of at least three biological replicates are shown. B, qRT-PCR detection of the YAP target genes CTGF and CYR61. KYSE450 cells expressing EV or D-AS2 were pretreated with FIPI (30 mmol/L) or CAY10594 (20 mmol/L) for 1 hour. The data are presented as the mean SD values; two-tailed t test; , P < 0.001; n ¼ 3 technical replicates. C and D, IF detection of YAP localization in KYSE450 cells expressing EV or D-AS2. Cells were pre- treated with FIPI (30 mmol/L) or CAY10594 (20 mmol/L). YAP localization is shown in C. Scale bar, 30 mm. Cells from three different fields in three independent experiments were randomly selected for quantification of YAP localization (D). The data are expressed as the mean SEM values. E, Western blot analyses of YAP and LATS1 phosphorylation. Serum-starved KYSE30 cells expressing control or D-AS2–target- ing sgRNAs were pretreated with PA (100 mmol/L) for 1 hour. Representative results of at least three biological replicates are shown. F, qRT-PCR detection of the YAP target genes CTGF and CYR61. Serum- starved KYSE30 cells expressing control or D-AS2–targeting sgRNAs were pretreated with PA (100 mmol/L) for 1 hour. The data are presented as the mean SD values; two-tailed t test; , P < 0.001; ns, not significant; n ¼ 3 technical replicates. G and H, IF detection of YAP localization in KYSE30 cells expressing control and D-AS2–targeting sgRNAs and pretreated with PA (100 mmol/L) for 1 hour. YAP local- ization is shown in G. Scale bar, 30 mm. Cells from three different fields in three independent experiments were randomly selected for quantification of YAP localiza- tion (H). The data are expressed as the mean SEM values. I, qRT-PCR detection of the expression of the indicated genes in the samples with chemoresistance or chemosensitivity of patients with esoph- ageal SCC. The data are presented as the mean SEM values; two-tailed t test; n ¼ 17 for chemoresistant patients; n ¼ 17 for chemosensitive patients.
    Cay10594, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cay10594/cay10594/pm38703555-46-3-15
    Average 90 stars, based on 1 article reviews
    cay10594 - by Bioz Stars, 2026-08
    90/100 stars
      Buy from Supplier

    90
    Cayman Chemical pld2 inhibitor cay10594
    Figure 6. D-AS2 promotes PLD/PA-mediated YAP activation. A, Western blot analyses of YAP and LATS1 phosphorylation. KYSE450 cells expressing EV or D-AS2 were pretreated with FIPI (30 mmol/L) or <t>CAY10594</t> (20 mmol/L) for 1 hour. Representative results of at least three biological replicates are shown. B, qRT-PCR detection of the YAP target genes CTGF and CYR61. KYSE450 cells expressing EV or D-AS2 were pretreated with FIPI (30 mmol/L) or CAY10594 (20 mmol/L) for 1 hour. The data are presented as the mean SD values; two-tailed t test; , P < 0.001; n ¼ 3 technical replicates. C and D, IF detection of YAP localization in KYSE450 cells expressing EV or D-AS2. Cells were pre- treated with FIPI (30 mmol/L) or CAY10594 (20 mmol/L). YAP localization is shown in C. Scale bar, 30 mm. Cells from three different fields in three independent experiments were randomly selected for quantification of YAP localization (D). The data are expressed as the mean SEM values. E, Western blot analyses of YAP and LATS1 phosphorylation. Serum-starved KYSE30 cells expressing control or D-AS2–target- ing sgRNAs were pretreated with PA (100 mmol/L) for 1 hour. Representative results of at least three biological replicates are shown. F, qRT-PCR detection of the YAP target genes CTGF and CYR61. Serum- starved KYSE30 cells expressing control or D-AS2–targeting sgRNAs were pretreated with PA (100 mmol/L) for 1 hour. The data are presented as the mean SD values; two-tailed t test; , P < 0.001; ns, not significant; n ¼ 3 technical replicates. G and H, IF detection of YAP localization in KYSE30 cells expressing control and D-AS2–targeting sgRNAs and pretreated with PA (100 mmol/L) for 1 hour. YAP local- ization is shown in G. Scale bar, 30 mm. Cells from three different fields in three independent experiments were randomly selected for quantification of YAP localiza- tion (H). The data are expressed as the mean SEM values. I, qRT-PCR detection of the expression of the indicated genes in the samples with chemoresistance or chemosensitivity of patients with esoph- ageal SCC. The data are presented as the mean SEM values; two-tailed t test; n ¼ 17 for chemoresistant patients; n ¼ 17 for chemosensitive patients.
    Pld2 Inhibitor Cay10594, supplied by Cayman Chemical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cay10594/pld1+inhibitor+vu0155069/pm37691020-68-24-28
    Average 90 stars, based on 1 article reviews
    pld2 inhibitor cay10594 - by Bioz Stars, 2026-08
    90/100 stars
      Buy from Supplier

    90
    Cayman Chemical cay10594
    Figure 6. D-AS2 promotes PLD/PA-mediated YAP activation. A, Western blot analyses of YAP and LATS1 phosphorylation. KYSE450 cells expressing EV or D-AS2 were pretreated with FIPI (30 mmol/L) or <t>CAY10594</t> (20 mmol/L) for 1 hour. Representative results of at least three biological replicates are shown. B, qRT-PCR detection of the YAP target genes CTGF and CYR61. KYSE450 cells expressing EV or D-AS2 were pretreated with FIPI (30 mmol/L) or CAY10594 (20 mmol/L) for 1 hour. The data are presented as the mean SD values; two-tailed t test; , P < 0.001; n ¼ 3 technical replicates. C and D, IF detection of YAP localization in KYSE450 cells expressing EV or D-AS2. Cells were pre- treated with FIPI (30 mmol/L) or CAY10594 (20 mmol/L). YAP localization is shown in C. Scale bar, 30 mm. Cells from three different fields in three independent experiments were randomly selected for quantification of YAP localization (D). The data are expressed as the mean SEM values. E, Western blot analyses of YAP and LATS1 phosphorylation. Serum-starved KYSE30 cells expressing control or D-AS2–target- ing sgRNAs were pretreated with PA (100 mmol/L) for 1 hour. Representative results of at least three biological replicates are shown. F, qRT-PCR detection of the YAP target genes CTGF and CYR61. Serum- starved KYSE30 cells expressing control or D-AS2–targeting sgRNAs were pretreated with PA (100 mmol/L) for 1 hour. The data are presented as the mean SD values; two-tailed t test; , P < 0.001; ns, not significant; n ¼ 3 technical replicates. G and H, IF detection of YAP localization in KYSE30 cells expressing control and D-AS2–targeting sgRNAs and pretreated with PA (100 mmol/L) for 1 hour. YAP local- ization is shown in G. Scale bar, 30 mm. Cells from three different fields in three independent experiments were randomly selected for quantification of YAP localiza- tion (H). The data are expressed as the mean SEM values. I, qRT-PCR detection of the expression of the indicated genes in the samples with chemoresistance or chemosensitivity of patients with esoph- ageal SCC. The data are presented as the mean SEM values; two-tailed t test; n ¼ 17 for chemoresistant patients; n ¼ 17 for chemosensitive patients.
    Cay10594, supplied by Cayman Chemical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cay10594/cay10598/ppr0504770-67-25-20
    Average 90 stars, based on 1 article reviews
    cay10594 - by Bioz Stars, 2026-08
    90/100 stars
      Buy from Supplier

    90
    Topscience Co Ltd cay10594 (1130067-34-3)
    ( A ) IB detection of YAP and LATS1 phosphorylation. KYSE450 cells expressing empty vector (EV) and D-AS2 were pretreated with FIPI (30 µM) or <t>CAY10594</t> (20 µM) for 1 h. ( B ) RT-qPCR detection of the YAP target genes CTGF and CYR61. KYSE450 cells expressing EV and D-AS2 were pretreated with FIPI (30 µM) or CAY10594 (20 µM) for 1 h. The data are presented as the mean ± s.d. values; two-tailed t test, *** P < 0.001; n = 3. ( C, D ) IF detection of YAP localization in KYSE450 cells expressing EV and D-AS2. Cells were pretreated with FIPI (30 µM) or CAY10594 (20 µM). YAP localization is shown in (C); scale bar, 30 µm. Cells from three different fields in three independent experiments were randomly selected for quantification of YAP localization (D). The data are expressed as the mean ± s.e.m. values. ( E ) IB detection of YAP and LATS1 phosphorylation. Serum-starved KYSE30 cells expressing control or D-AS2-targeting sgRNAs were pretreated with PA (100 µM) for 1 h. ( F ) RT-qPCR detection of the YAP target genes CTGF and CYR61. Serum-starved KYSE30 cells expressing control or D-AS2-targeting sgRNAs were pretreated with PA (100 µM) for 1 h. The data are presented as the mean ± s.d. values; two-tailed t test, *** P < 0.001, ns: not significant; n = 3. ( G, H ) IF detection of YAP localization in KYSE30 cells expressing control and D-AS2-targeting sgRNAs and pretreated with PA (100 µM) for 1 h. YAP localization is shown in (G); scale bar, 30 µm. Cells from three different fields in three independent experiments were randomly selected for quantification of YAP localization (H). The data are expressed as the mean ± s.e.m. values. ( I ) RT-qPCR detection of the indicated genes expression in the samples with chemoresistance or chemosensitivity of esophageal SCC patients. The data are presented as the mean ± s.e.m. values; two-tailed t test; n = 17 for chemoresistant patients; n = 17 for chemosensitive patients.
    Cay10594 (1130067 34 3), supplied by Topscience Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cay10594/cay10594++1130067+34+3+/bio_rxiv__2022__02__24__481869-70-3-8
    Average 90 stars, based on 1 article reviews
    cay10594 (1130067-34-3) - by Bioz Stars, 2026-08
    90/100 stars
      Buy from Supplier

    92
    Santa Cruz Biotechnology cay10594 inhibitor
    ( A ) IB detection of YAP and LATS1 phosphorylation. KYSE450 cells expressing empty vector (EV) and D-AS2 were pretreated with FIPI (30 µM) or <t>CAY10594</t> (20 µM) for 1 h. ( B ) RT-qPCR detection of the YAP target genes CTGF and CYR61. KYSE450 cells expressing EV and D-AS2 were pretreated with FIPI (30 µM) or CAY10594 (20 µM) for 1 h. The data are presented as the mean ± s.d. values; two-tailed t test, *** P < 0.001; n = 3. ( C, D ) IF detection of YAP localization in KYSE450 cells expressing EV and D-AS2. Cells were pretreated with FIPI (30 µM) or CAY10594 (20 µM). YAP localization is shown in (C); scale bar, 30 µm. Cells from three different fields in three independent experiments were randomly selected for quantification of YAP localization (D). The data are expressed as the mean ± s.e.m. values. ( E ) IB detection of YAP and LATS1 phosphorylation. Serum-starved KYSE30 cells expressing control or D-AS2-targeting sgRNAs were pretreated with PA (100 µM) for 1 h. ( F ) RT-qPCR detection of the YAP target genes CTGF and CYR61. Serum-starved KYSE30 cells expressing control or D-AS2-targeting sgRNAs were pretreated with PA (100 µM) for 1 h. The data are presented as the mean ± s.d. values; two-tailed t test, *** P < 0.001, ns: not significant; n = 3. ( G, H ) IF detection of YAP localization in KYSE30 cells expressing control and D-AS2-targeting sgRNAs and pretreated with PA (100 µM) for 1 h. YAP localization is shown in (G); scale bar, 30 µm. Cells from three different fields in three independent experiments were randomly selected for quantification of YAP localization (H). The data are expressed as the mean ± s.e.m. values. ( I ) RT-qPCR detection of the indicated genes expression in the samples with chemoresistance or chemosensitivity of esophageal SCC patients. The data are presented as the mean ± s.e.m. values; two-tailed t test; n = 17 for chemoresistant patients; n = 17 for chemosensitive patients.
    Cay10594 Inhibitor, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cay10594/CAY10594/pm33343836-147-1-10
    Average 92 stars, based on 1 article reviews
    cay10594 inhibitor - by Bioz Stars, 2026-08
    92/100 stars
      Buy from Supplier

    Image Search Results


    Figure 6. D-AS2 promotes PLD/PA-mediated YAP activation. A, Western blot analyses of YAP and LATS1 phosphorylation. KYSE450 cells expressing EV or D-AS2 were pretreated with FIPI (30 mmol/L) or CAY10594 (20 mmol/L) for 1 hour. Representative results of at least three biological replicates are shown. B, qRT-PCR detection of the YAP target genes CTGF and CYR61. KYSE450 cells expressing EV or D-AS2 were pretreated with FIPI (30 mmol/L) or CAY10594 (20 mmol/L) for 1 hour. The data are presented as the mean SD values; two-tailed t test; , P < 0.001; n ¼ 3 technical replicates. C and D, IF detection of YAP localization in KYSE450 cells expressing EV or D-AS2. Cells were pre- treated with FIPI (30 mmol/L) or CAY10594 (20 mmol/L). YAP localization is shown in C. Scale bar, 30 mm. Cells from three different fields in three independent experiments were randomly selected for quantification of YAP localization (D). The data are expressed as the mean SEM values. E, Western blot analyses of YAP and LATS1 phosphorylation. Serum-starved KYSE30 cells expressing control or D-AS2–target- ing sgRNAs were pretreated with PA (100 mmol/L) for 1 hour. Representative results of at least three biological replicates are shown. F, qRT-PCR detection of the YAP target genes CTGF and CYR61. Serum- starved KYSE30 cells expressing control or D-AS2–targeting sgRNAs were pretreated with PA (100 mmol/L) for 1 hour. The data are presented as the mean SD values; two-tailed t test; , P < 0.001; ns, not significant; n ¼ 3 technical replicates. G and H, IF detection of YAP localization in KYSE30 cells expressing control and D-AS2–targeting sgRNAs and pretreated with PA (100 mmol/L) for 1 hour. YAP local- ization is shown in G. Scale bar, 30 mm. Cells from three different fields in three independent experiments were randomly selected for quantification of YAP localiza- tion (H). The data are expressed as the mean SEM values. I, qRT-PCR detection of the expression of the indicated genes in the samples with chemoresistance or chemosensitivity of patients with esoph- ageal SCC. The data are presented as the mean SEM values; two-tailed t test; n ¼ 17 for chemoresistant patients; n ¼ 17 for chemosensitive patients.

    Journal: Cancer Research

    Article Title: DLGAP1-AS2–Mediated Phosphatidic Acid Synthesis Activates YAP Signaling and Confers Chemoresistance in Squamous Cell Carcinoma

    doi: 10.1158/0008-5472.can-22-0717

    Figure Lengend Snippet: Figure 6. D-AS2 promotes PLD/PA-mediated YAP activation. A, Western blot analyses of YAP and LATS1 phosphorylation. KYSE450 cells expressing EV or D-AS2 were pretreated with FIPI (30 mmol/L) or CAY10594 (20 mmol/L) for 1 hour. Representative results of at least three biological replicates are shown. B, qRT-PCR detection of the YAP target genes CTGF and CYR61. KYSE450 cells expressing EV or D-AS2 were pretreated with FIPI (30 mmol/L) or CAY10594 (20 mmol/L) for 1 hour. The data are presented as the mean SD values; two-tailed t test; , P < 0.001; n ¼ 3 technical replicates. C and D, IF detection of YAP localization in KYSE450 cells expressing EV or D-AS2. Cells were pre- treated with FIPI (30 mmol/L) or CAY10594 (20 mmol/L). YAP localization is shown in C. Scale bar, 30 mm. Cells from three different fields in three independent experiments were randomly selected for quantification of YAP localization (D). The data are expressed as the mean SEM values. E, Western blot analyses of YAP and LATS1 phosphorylation. Serum-starved KYSE30 cells expressing control or D-AS2–target- ing sgRNAs were pretreated with PA (100 mmol/L) for 1 hour. Representative results of at least three biological replicates are shown. F, qRT-PCR detection of the YAP target genes CTGF and CYR61. Serum- starved KYSE30 cells expressing control or D-AS2–targeting sgRNAs were pretreated with PA (100 mmol/L) for 1 hour. The data are presented as the mean SD values; two-tailed t test; , P < 0.001; ns, not significant; n ¼ 3 technical replicates. G and H, IF detection of YAP localization in KYSE30 cells expressing control and D-AS2–targeting sgRNAs and pretreated with PA (100 mmol/L) for 1 hour. YAP local- ization is shown in G. Scale bar, 30 mm. Cells from three different fields in three independent experiments were randomly selected for quantification of YAP localiza- tion (H). The data are expressed as the mean SEM values. I, qRT-PCR detection of the expression of the indicated genes in the samples with chemoresistance or chemosensitivity of patients with esoph- ageal SCC. The data are presented as the mean SEM values; two-tailed t test; n ¼ 17 for chemoresistant patients; n ¼ 17 for chemosensitive patients.

    Article Snippet: FIPI (939055-18-2) and CAY10594 (1130067-34-3) were purchased from Topscience.

    Techniques: Activation Assay, Western Blot, Phospho-proteomics, Expressing, Quantitative RT-PCR, Two Tailed Test, Control

    ( A ) IB detection of YAP and LATS1 phosphorylation. KYSE450 cells expressing empty vector (EV) and D-AS2 were pretreated with FIPI (30 µM) or CAY10594 (20 µM) for 1 h. ( B ) RT-qPCR detection of the YAP target genes CTGF and CYR61. KYSE450 cells expressing EV and D-AS2 were pretreated with FIPI (30 µM) or CAY10594 (20 µM) for 1 h. The data are presented as the mean ± s.d. values; two-tailed t test, *** P < 0.001; n = 3. ( C, D ) IF detection of YAP localization in KYSE450 cells expressing EV and D-AS2. Cells were pretreated with FIPI (30 µM) or CAY10594 (20 µM). YAP localization is shown in (C); scale bar, 30 µm. Cells from three different fields in three independent experiments were randomly selected for quantification of YAP localization (D). The data are expressed as the mean ± s.e.m. values. ( E ) IB detection of YAP and LATS1 phosphorylation. Serum-starved KYSE30 cells expressing control or D-AS2-targeting sgRNAs were pretreated with PA (100 µM) for 1 h. ( F ) RT-qPCR detection of the YAP target genes CTGF and CYR61. Serum-starved KYSE30 cells expressing control or D-AS2-targeting sgRNAs were pretreated with PA (100 µM) for 1 h. The data are presented as the mean ± s.d. values; two-tailed t test, *** P < 0.001, ns: not significant; n = 3. ( G, H ) IF detection of YAP localization in KYSE30 cells expressing control and D-AS2-targeting sgRNAs and pretreated with PA (100 µM) for 1 h. YAP localization is shown in (G); scale bar, 30 µm. Cells from three different fields in three independent experiments were randomly selected for quantification of YAP localization (H). The data are expressed as the mean ± s.e.m. values. ( I ) RT-qPCR detection of the indicated genes expression in the samples with chemoresistance or chemosensitivity of esophageal SCC patients. The data are presented as the mean ± s.e.m. values; two-tailed t test; n = 17 for chemoresistant patients; n = 17 for chemosensitive patients.

    Journal: bioRxiv

    Article Title: DLGAP1-AS2-Mediated Phosphatidic Acid Synthesis Confers Chemoresistance via Activation of YAP Signaling

    doi: 10.1101/2022.02.24.481869

    Figure Lengend Snippet: ( A ) IB detection of YAP and LATS1 phosphorylation. KYSE450 cells expressing empty vector (EV) and D-AS2 were pretreated with FIPI (30 µM) or CAY10594 (20 µM) for 1 h. ( B ) RT-qPCR detection of the YAP target genes CTGF and CYR61. KYSE450 cells expressing EV and D-AS2 were pretreated with FIPI (30 µM) or CAY10594 (20 µM) for 1 h. The data are presented as the mean ± s.d. values; two-tailed t test, *** P < 0.001; n = 3. ( C, D ) IF detection of YAP localization in KYSE450 cells expressing EV and D-AS2. Cells were pretreated with FIPI (30 µM) or CAY10594 (20 µM). YAP localization is shown in (C); scale bar, 30 µm. Cells from three different fields in three independent experiments were randomly selected for quantification of YAP localization (D). The data are expressed as the mean ± s.e.m. values. ( E ) IB detection of YAP and LATS1 phosphorylation. Serum-starved KYSE30 cells expressing control or D-AS2-targeting sgRNAs were pretreated with PA (100 µM) for 1 h. ( F ) RT-qPCR detection of the YAP target genes CTGF and CYR61. Serum-starved KYSE30 cells expressing control or D-AS2-targeting sgRNAs were pretreated with PA (100 µM) for 1 h. The data are presented as the mean ± s.d. values; two-tailed t test, *** P < 0.001, ns: not significant; n = 3. ( G, H ) IF detection of YAP localization in KYSE30 cells expressing control and D-AS2-targeting sgRNAs and pretreated with PA (100 µM) for 1 h. YAP localization is shown in (G); scale bar, 30 µm. Cells from three different fields in three independent experiments were randomly selected for quantification of YAP localization (H). The data are expressed as the mean ± s.e.m. values. ( I ) RT-qPCR detection of the indicated genes expression in the samples with chemoresistance or chemosensitivity of esophageal SCC patients. The data are presented as the mean ± s.e.m. values; two-tailed t test; n = 17 for chemoresistant patients; n = 17 for chemosensitive patients.

    Article Snippet: FIPI (939055-18-2) and CAY10594 (1130067-34-3) were purchased from Topscience (Topscience; Shanghai, China).

    Techniques: Expressing, Plasmid Preparation, Quantitative RT-PCR, Two Tailed Test